Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Expanding US FDA Mandatory Recall Authority To All Drugs Gets House Appropriators’ Approval

Jul 13 2020

• By Malcolm Spicer

White lightbox with word fda recall on wood background

Related Content

Zero Count Adds Up To 70,000-Bottle Ranitidine Recall For AuroMedics

Nov 11 2019

DeLauro Renews Push To Give FDA Mandatory Recall Authority For Drugs

Jan 12 2020

US FDA Requests Ranitidine Removal But Also Encourages Research For Stable Formulations

Apr 02 2020

US House Appropriators Request CBD Enforcement As They Ante Up $5M For FDA's Rule Development

Jul 10 2020

'Mock' Recalls Suggested, But US FDA Isn't Joking About Recalling Products

Apr 24 2019

Additional Topics

United States Legislation Recalls OTC Drugs Advertising, Marketing & Sales Commercial Compliance Dietary Supplements Distribution Enforcement FDA Ingredients Manufacturing Policy Regulation Safety Consumer

More from Legislation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window